Board logo

subject: Japan In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 [print this page]



Japan In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Japan In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Japan

Scope

- The report provides inforamtion on the Japanese in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.

- Total revenues, end users

- Market shares of all the key competitors.

- Key pipeline products that are set to shape the market, broken down by sector.

- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.

- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.

- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

- Key mergers and acquisitions, partnerships, private equity investments and IPOs.

- Customer, hospitals and physicians data. F. Hoffmann-La Roche Ltd.

Siemens Healthcare

Sysmex Corporation

Abbott Laboratories

Beckman Coulter, Inc.

Ortho-Clinical Diagnostics Inc.

OLYMPUS CORPORATION

Qiagen N.V.

bioMerieux S.A.

Bio-Rad Laboratories, Inc.

Phadia AB

DiaSorin S.p.A

Becton, Dickinson and Company

Gen-Probe Incorporated

Inverness Medical Innovations, Inc.

Hologic, Inc.

Dade Behring Holdings, Inc.

Eiken Chemical Co.,Ltd.

Shionogi & Co., Ltd.

Cosmo Bio Co., Ltd.

Techno Medica Co., Ltd.

HORIBA, Ltd.

Kyowa Hakko Kirin Co., Ltd. For more information, please visit :

http://www.aarkstore.com/reports/Japan-In-Vitro-Diagnostics-Investment-Opportunities-Analysis-and-Forecasts-to-2015-7816.html

Or email us at press@aarkstore.com or call +919272852585

Japan In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

By: Aarkstore Enterprise




welcome to Insurances.net (https://www.insurances.net) Powered by Discuz! 5.5.0   (php7, mysql8 recode on 2018)